OMID
Price
$0.02
Change
-$0.01 (-33.33%)
Updated
Aug 15 closing price
Capitalization
1.7M
18 days until earnings call
RGEDF
Price
$27.17
Change
+$2.26 (+9.07%)
Updated
Jul 19 closing price
Capitalization
5.69B
Interact to see
Advertisement

OMID vs RGEDF

Header iconOMID vs RGEDF Comparison
Open Charts OMID vs RGEDFBanner chart's image
Omid
Price$0.02
Change-$0.01 (-33.33%)
Volume$185.27K
Capitalization1.7M
Gedeon Richter
Price$27.17
Change+$2.26 (+9.07%)
Volume$3
Capitalization5.69B
OMID vs RGEDF Comparison Chart in %
Loading...
OMID
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OMID vs. RGEDF commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OMID is a Hold and RGEDF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 16, 2025
Stock price -- (OMID: $0.02 vs. RGEDF: $27.17)
Brand notoriety: OMID and RGEDF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: OMID: 265% vs. RGEDF: 100%
Market capitalization -- OMID: $1.7M vs. RGEDF: $5.69B
OMID [@Pharmaceuticals: Generic] is valued at $1.7M. RGEDF’s [@Pharmaceuticals: Generic] market capitalization is $5.69B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OMID’s FA Score shows that 1 FA rating(s) are green whileRGEDF’s FA Score has 1 green FA rating(s).

  • OMID’s FA Score: 1 green, 4 red.
  • RGEDF’s FA Score: 1 green, 4 red.
According to our system of comparison, both OMID and RGEDF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OMID’s TA Score shows that 4 TA indicator(s) are bullish.

  • OMID’s TA Score: 4 bullish, 4 bearish.

Price Growth

OMID (@Pharmaceuticals: Generic) experienced а -26.36% price change this week, while RGEDF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +4.25%. For the same industry, the average monthly price growth was +10.98%, and the average quarterly price growth was +78.05%.

Reported Earning Dates

OMID is expected to report earnings on Sep 03, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+4.25% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGEDF($5.69B) has a higher market cap than OMID($1.7M). RGEDF YTD gains are higher at: 0.000 vs. OMID (-10.886).
OMIDRGEDFOMID / RGEDF
Capitalization1.7M5.69B0%
EBITDAN/A374B-
Gain YTD-10.8860.000-
P/E RatioN/A7.99-
RevenueN/A878B-
Total CashN/A202B-
Total DebtN/A21.3B-
FUNDAMENTALS RATINGS
OMID vs RGEDF: Fundamental Ratings
OMID
RGEDF
OUTLOOK RATING
1..100
2934
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
3
Undervalued
PROFIT vs RISK RATING
1..100
9774
SMR RATING
1..100
147
PRICE GROWTH RATING
1..100
3870
P/E GROWTH RATING
1..100
6887
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RGEDF's Valuation (3) in the null industry is significantly better than the same rating for OMID (81). This means that RGEDF’s stock grew significantly faster than OMID’s over the last 12 months.

RGEDF's Profit vs Risk Rating (74) in the null industry is in the same range as OMID (97). This means that RGEDF’s stock grew similarly to OMID’s over the last 12 months.

OMID's SMR Rating (1) in the null industry is somewhat better than the same rating for RGEDF (47). This means that OMID’s stock grew somewhat faster than RGEDF’s over the last 12 months.

OMID's Price Growth Rating (38) in the null industry is in the same range as RGEDF (70). This means that OMID’s stock grew similarly to RGEDF’s over the last 12 months.

OMID's P/E Growth Rating (68) in the null industry is in the same range as RGEDF (87). This means that OMID’s stock grew similarly to RGEDF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OMIDRGEDF
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
N/A
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
24%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
20%
Advances
ODDS (%)
Bullish Trend 18 days ago
88%
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
OMID
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LICYX18.12N/A
N/A
Lord Abbett International Equity I
SHRAX108.17N/A
N/A
ClearBridge Growth A
CVMRX20.69N/A
N/A
Calvert Emerging Markets Equity R6
VYMRX16.72N/A
N/A
Voya MI Dynamic SMID Cap C
RLBBX37.10-0.09
-0.24%
American Funds American Balanced R2

OMID and

Correlation & Price change

A.I.dvisor tells us that OMID and OWPC have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OMID and OWPC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OMID
1D Price
Change %
OMID100%
-32.31%
OWPC - OMID
10%
Poorly correlated
+25.00%
OILFF - OMID
9%
Poorly correlated
+0.26%
RGEDF - OMID
6%
Poorly correlated
N/A
RAFA - OMID
3%
Poorly correlated
+6.55%
PHCUF - OMID
3%
Poorly correlated
N/A
More

RGEDF and

Correlation & Price change

A.I.dvisor tells us that RGEDF and YCBD have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RGEDF and YCBD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGEDF
1D Price
Change %
RGEDF100%
N/A
YCBD - RGEDF
28%
Poorly correlated
-10.98%
OMID - RGEDF
6%
Poorly correlated
-32.31%
OVATF - RGEDF
6%
Poorly correlated
N/A
PCLOF - RGEDF
5%
Poorly correlated
-23.05%
OWPC - RGEDF
4%
Poorly correlated
+25.00%
More